ORIC® Pharmaceuticals to Participate in Upcoming Investor Conferences
ORIC Pharmaceuticals will present at three September 2026 healthcare investor conferences, with fireside chats webcast live and archived for 90 days.
Rhea-AI Summary
ORIC Pharmaceuticals (ORIC) will participate in three healthcare investor conferences in September 2026, featuring management fireside chats and one-on-one meetings.
Events include the Wells Fargo 21st Annual Healthcare Conference on September 9 at 2:15 p.m. ET, the Cantor Global Healthcare Conference on September 10 at 1:35 p.m. ET, and the Morgan Stanley 24th Annual Global Healthcare Conference on September 15 at 10:00 a.m. ET. Live webcasts and 90-day replays will be accessible via the investor section of the company website.
Positive
- None.
Negative
- None.
AI-generated analysis. How Rhea-AI works. Not financial advice.
SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, Sept. 02, 2026 (GLOBE NEWSWIRE) -- ORIC Pharmaceuticals, Inc. (Nasdaq: ORIC), a clinical stage oncology company focused on developing and commercializing treatments that address mechanisms of therapeutic resistance, today announced that management will be participating in the following investor conferences in September:
- Wells Fargo 21st Annual Healthcare Conference – Participating in a fireside chat on Wednesday, September 9, 2026, at 2:15 p.m. ET. Management will also be participating in one-on-one meetings.
- 2026 Cantor Global Healthcare Conference – Participating in a fireside chat on Thursday, September 10, 2026, at 1:35 p.m. ET. Management will also be participating in one-on-one meetings.
- Morgan Stanley 24th Annual Global Healthcare Conference – Participating in a fireside chat on Tuesday, September 15, 2026, at 10:00 a.m. ET. Management will also be participating in one-on-one meetings.
Webcasts of the fireside chat discussions will be available through the investor section of the company’s website at www.oricpharma.com. Replays of the webcasts will be available for 90 days following the event.
About ORIC Pharmaceuticals, Inc.
ORIC Pharmaceuticals is a clinical stage biopharmaceutical company dedicated to improving patients’ lives by Overcoming Resistance In Cancer. ORIC’s clinical stage product candidates include (1) rinzimetostat, an allosteric inhibitor of the polycomb repressive complex 2 (PRC2) via the EED subunit, being developed for prostate cancer, and (2) enozertinib, a brain-penetrant inhibitor targeting EGFR exon 20 insertion and EGFR atypical mutations, being developed for NSCLC. ORIC has offices in South San Francisco and San Diego, California. For more information, please go to www.oricpharma.com, and follow us on X or LinkedIn.
Contact:
Dominic Piscitelli, Chief Financial Officer
dominic.piscitelli@oricpharma.com
info@oricpharma.com
FAQ
When will ORIC (ORIC) present at the Wells Fargo 21st Annual Healthcare Conference?
ORIC management will participate in a fireside chat at the Wells Fargo 21st Annual Healthcare Conference on Wednesday, September 9, 2026, at 2:15 p.m. ET. Management will also take part in one-on-one investor meetings during the conference.
What is the schedule for ORIC (ORIC) at the 2026 Cantor Global Healthcare Conference?
At the 2026 Cantor Global Healthcare Conference, ORIC management will join a fireside chat on Thursday, September 10, 2026, at 1:35 p.m. ET. The company also plans to hold one-on-one meetings with investors during the event.
When is ORIC (ORIC) speaking at the Morgan Stanley 24th Annual Global Healthcare Conference?
ORIC is scheduled for a fireside chat at the Morgan Stanley 24th Annual Global Healthcare Conference on Tuesday, September 15, 2026, at 10:00 a.m. ET. Management will additionally participate in one-on-one investor meetings at this conference.
How can investors access the ORIC (ORIC) conference webcasts in September 2026?
Live webcasts of ORIC’s September 2026 fireside chats will be available through the investor section of www.oricpharma.com. Replays of each webcast will be accessible on the website for 90 days following the respective event.